Immunotherapy, chemotherapy, stem cell transplantation, targeted therapy, monoclonal antibody therapy, and radiation therapy are among Non-Hodgkins Lymphoma Treatment. If the patient's blood thickens owing to the presence of antibodies, plasmapheresis can be performed. Deltasone, Adcertis, Folotyn, Adriamycin, Prednicot, Leukeran, Velcade, Thioplex, and Decadron are some of the lymphoma treatments available. The upcoming release of new medications is likely to help the expansion of the non-Hodgkins lymphoma therapy industry. Axicabtagene ciloleucel, for example, got priority review status in order to be commercialised for the treatment of non-Hodgkins lymphoma as a second line therapy. This medication is scheduled to be available in late 2017.
Know more- https://cmiblogdailydose.blogspot.com/2022/07/non-hodgkins-lymphoma-treatment-varies.html
